Ascendent Capital Partners has successfully acquired Hollysys Automation Technologies Ltd. for approximately US$1.66 billion, enhancing its capabilities within China's growing automation and biopharmaceutical sectors.
Target Information
Hollysys Automation Technologies Ltd. is a prominent provider of automation control systems in China, recognized for its innovative solutions across various sectors. Established in 1993, Hollysys boasts a strong portfolio that addresses complex automation needs, particularly in industries such as manufacturing, transportation, and energy.
The company has earned a reputation for utilizing cutting-edge technology to enhance operational efficiency and reliability. Hollysys has been a key player in China's automation landscape, contributing to myriad projects that have fostered advancements in industrial automation processes.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in China
The automation industry in China has witnessed significant growth due to the country's ongoing industrial transformation and modernization efforts. Robust investment in technology infrastructure, fueled
Similar Deals
Hillhouse Investment Management → WuXi AppTec’s China-based clinical research services business
2025
GL Capital Group → Huizhou Foryou Medical Devices Co., Ltd
2023
Hygeia Healthcare → Suzhou Yongding Hospital
2021
Ascendent Capital Partners
invested in
Hollysys Automation Technologies Ltd.
in 2024
in a Buyout deal
Disclosed details
Transaction Size: $1,660M
Enterprise Value: $1,660M
Equity Value: $1,660M